MEMS Adherence Monitoring System chosen for trials of HIV-prevention medication in Africa and India

DEC-2014 : Grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials

MWV’s MEMS® System chosen for trials of HIV-prevention medication in Africa and India.

Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials

 

 

BMGF-medAmigo.png
Back to news

Further information and contact

  • info@aardexgroup.com
  • +32 4 374 86 30
  • TheLabs - Liege Science Park

    15/1 rue bois St Jean

    4102 Seraing
    Belgium

  • 29, Avenue de la Gare

    1950 Sion
    Switzerland